QQQ   389.27 (+0.03%)
AAPL   190.23 (+0.23%)
MSFT   381.70 (+0.82%)
META   336.11 (+0.42%)
GOOGL   136.28 (-0.10%)
AMZN   146.59 (-0.77%)
TSLA   237.57 (+0.63%)
NVDA   476.91 (-1.14%)
NIO   7.19 (+0.00%)
BABA   76.13 (-1.81%)
AMD   122.04 (-0.50%)
T   16.17 (-0.25%)
F   10.34 (+0.00%)
MU   75.02 (-3.21%)
CGC   0.53 (-2.41%)
GE   119.69 (-0.23%)
DIS   94.09 (-1.13%)
AMC   6.66 (-2.06%)
PFE   29.88 (-0.86%)
PYPL   57.10 (+1.26%)
XOM   104.59 (+0.61%)
QQQ   389.27 (+0.03%)
AAPL   190.23 (+0.23%)
MSFT   381.70 (+0.82%)
META   336.11 (+0.42%)
GOOGL   136.28 (-0.10%)
AMZN   146.59 (-0.77%)
TSLA   237.57 (+0.63%)
NVDA   476.91 (-1.14%)
NIO   7.19 (+0.00%)
BABA   76.13 (-1.81%)
AMD   122.04 (-0.50%)
T   16.17 (-0.25%)
F   10.34 (+0.00%)
MU   75.02 (-3.21%)
CGC   0.53 (-2.41%)
GE   119.69 (-0.23%)
DIS   94.09 (-1.13%)
AMC   6.66 (-2.06%)
PFE   29.88 (-0.86%)
PYPL   57.10 (+1.26%)
XOM   104.59 (+0.61%)
QQQ   389.27 (+0.03%)
AAPL   190.23 (+0.23%)
MSFT   381.70 (+0.82%)
META   336.11 (+0.42%)
GOOGL   136.28 (-0.10%)
AMZN   146.59 (-0.77%)
TSLA   237.57 (+0.63%)
NVDA   476.91 (-1.14%)
NIO   7.19 (+0.00%)
BABA   76.13 (-1.81%)
AMD   122.04 (-0.50%)
T   16.17 (-0.25%)
F   10.34 (+0.00%)
MU   75.02 (-3.21%)
CGC   0.53 (-2.41%)
GE   119.69 (-0.23%)
DIS   94.09 (-1.13%)
AMC   6.66 (-2.06%)
PFE   29.88 (-0.86%)
PYPL   57.10 (+1.26%)
XOM   104.59 (+0.61%)
QQQ   389.27 (+0.03%)
AAPL   190.23 (+0.23%)
MSFT   381.70 (+0.82%)
META   336.11 (+0.42%)
GOOGL   136.28 (-0.10%)
AMZN   146.59 (-0.77%)
TSLA   237.57 (+0.63%)
NVDA   476.91 (-1.14%)
NIO   7.19 (+0.00%)
BABA   76.13 (-1.81%)
AMD   122.04 (-0.50%)
T   16.17 (-0.25%)
F   10.34 (+0.00%)
MU   75.02 (-3.21%)
CGC   0.53 (-2.41%)
GE   119.69 (-0.23%)
DIS   94.09 (-1.13%)
AMC   6.66 (-2.06%)
PFE   29.88 (-0.86%)
PYPL   57.10 (+1.26%)
XOM   104.59 (+0.61%)

Geron (GERN) News Today

$1.92
+0.01 (+0.26%)
(As of 10:57 AM ET)
Compare
Today's Range
$1.85
$1.92
50-Day Range
$1.74
$2.19
52-Week Range
$1.68
$3.84
Volume
593,112 shs
Average Volume
6.58 million shs
Market Capitalization
$1.04 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.75
SourceHeadline
finance.yahoo.com logoGeron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors
finance.yahoo.com - November 28 at 8:39 AM
thestreet.com logoGeron (GERN) Stock Surges After FDA Removes Full Clinical Hold on Imetelstat Application
thestreet.com - November 21 at 8:55 PM
finance.yahoo.com logoGeron to Participate at Upcoming Investor Conferences in November
finance.yahoo.com - November 7 at 8:02 PM
markets.businessinsider.com logoGeron’s Growth Prospects: Expanding Commercial Team, Imetelstat Development, and Financial Stability
markets.businessinsider.com - November 3 at 10:30 AM
finance.yahoo.com logoGeron Corporation (NASDAQ:GERN) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 3 at 10:30 AM
fool.com logoGeron (GERN) Q3 2023 Earnings Call Transcript
fool.com - November 2 at 5:09 PM
seekingalpha.com logoGeron Corporation 2023 Q3 - Results - Earnings Call Presentation
seekingalpha.com - November 2 at 1:07 PM
markets.businessinsider.com logoGeron Corporation Q3 Loss beats estimates
markets.businessinsider.com - November 2 at 1:01 PM
finance.yahoo.com logoGeron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results
finance.yahoo.com - November 2 at 1:01 PM
finance.yahoo.com logoGeron IMerge Phase 3 Presentations at Upcoming ASH Annual Meeting Reinforce Significant Durability and Breadth of Effect of Imetelstat in Lower Risk MDS
finance.yahoo.com - November 2 at 1:01 PM
finance.yahoo.com logoGeron Corp (GERN) Reports Q3 2023 Financial Results and Business Highlights
finance.yahoo.com - November 2 at 1:01 PM
benzinga.com logo4GERN : Geron Earnings Preview
benzinga.com - November 1 at 3:32 PM
finance.yahoo.com logoTechne (TECH) Q1 Earnings and Revenues Miss Estimates
finance.yahoo.com - October 31 at 1:02 PM
finance.yahoo.com logoGeron to Announce Third Quarter 2023 Financial Results on November 2, 2023
finance.yahoo.com - October 26 at 6:35 PM
seekingalpha.com logoGeron Corporation Stock: Another Buying Opportunity
seekingalpha.com - October 23 at 4:07 PM
marketbeat.com logoRhumbline Advisers Has $2.27 Million Stake in Geron Co. (NASDAQ:GERN)
marketbeat.com - September 29 at 5:50 PM
markets.businessinsider.com logoGeron Reports EMA Validation Of Marketing Authorization Application For Imetelstat
markets.businessinsider.com - September 29 at 10:14 AM
finance.yahoo.com logoGeron Announces EMA Validation of Marketing Authorization Application for Imetelstat for the Treatment of Lower Risk MDS
finance.yahoo.com - September 29 at 10:14 AM
msn.com logoGoldman Sachs Upgrades Geron (GERN)
msn.com - September 13 at 12:31 AM
msn.com logoGeron Corporation: The FDA, Catalysts And New Competition From Old Drugs
msn.com - September 12 at 6:51 PM
marketbeat.com logoFairmount Funds Management LLC Invests $15.42 Million in Geron Co. (NASDAQ:GERN)
marketbeat.com - September 12 at 12:39 PM
marketwatch.com logoGeron Taps Michelle Robertson to Succeed Olivia Bloom as Finance Chief
marketwatch.com - September 11 at 9:42 PM
businesswire.com logoGeron Announces Appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer and Treasurer, and the Retirement of Olivia Bloom, Geron's Long-Time ...
businesswire.com - September 11 at 9:42 PM
msn.com logoGeron announces retirement of CFO Olivia Bloom; appoints Michelle Robertson as new CFO
msn.com - September 11 at 9:42 PM
finance.yahoo.com logoGeron Announces Appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer and Treasurer, and the Retirement of Olivia Bloom, Geron's Long-Time Chief Financial Officer
finance.yahoo.com - September 11 at 9:42 PM
finance.yahoo.com logoGeron Announces Data Presentations from IMerge Phase 3 Evaluating Imetelstat in Lower Risk MDS at Society of Hematologic Oncology Annual Meeting
finance.yahoo.com - September 7 at 4:23 PM
finance.yahoo.com logoGeron to Participate in the Baird 2023 Global Healthcare Conference
finance.yahoo.com - September 5 at 6:31 PM
marketbeat.com logoCitigroup Inc. Grows Stock Holdings in Geron Co. (NASDAQ:GERN)
marketbeat.com - September 5 at 4:52 AM
marketbeat.com logoPrivate Advisor Group LLC Makes New Investment in Geron Co. (NASDAQ:GERN)
marketbeat.com - September 4 at 5:32 AM
msn.com logoWedbush adds Geron to Best Ideas List, joining Ascendis, MoonLake
msn.com - September 1 at 5:49 PM
marketbeat.com logoShort Interest in Geron Co. (NASDAQ:GERN) Rises By 5.0%
marketbeat.com - September 1 at 5:46 PM
markets.businessinsider.com logoGeron (GERN) Gets a Buy from Robert W. Baird
markets.businessinsider.com - September 1 at 3:09 AM
markets.businessinsider.com logoWedbush Keeps Their Buy Rating on Geron (GERN)
markets.businessinsider.com - August 30 at 2:38 AM
marketbeat.com logoFY2023 EPS Estimates for Geron Co. Increased by Analyst (NASDAQ:GERN)
marketbeat.com - August 25 at 6:25 AM
seekingalpha.com logoFDA's Twist In Geron's Telomerase Tale (Rating Downgrade)
seekingalpha.com - August 23 at 1:00 PM
marketbeat.com logoMirae Asset Global Investments Co. Ltd. Acquires Shares of 80,666 Geron Co. (NASDAQ:GERN)
marketbeat.com - August 23 at 4:24 AM
seekingalpha.com logoGeron blood cancer therapy accepted for FDA standard review
seekingalpha.com - August 22 at 3:30 PM
markets.businessinsider.com logoGeron: FDA Assigns PDUFA Action Date For NDA For Imetelstat
markets.businessinsider.com - August 22 at 9:50 AM
finance.yahoo.com logoGeron Announces PDUFA Date for Imetelstat NDA in Lower Risk MDS
finance.yahoo.com - August 22 at 9:50 AM
markets.businessinsider.com logoFDA Accepts Geron's NDA For Imetelstat For Treatment Of Lower Risk Myelodysplastic Syndromes
markets.businessinsider.com - August 21 at 6:49 PM
finance.yahoo.com logoGeron Announces FDA Acceptance of New Drug Application for Imetelstat for the Treatment of Lower Risk MDS
finance.yahoo.com - August 21 at 6:49 PM
markets.businessinsider.com logoRobert W. Baird Remains a Buy on Geron (GERN)
markets.businessinsider.com - August 8 at 8:36 AM
marketbeat.com logoFY2026 EPS Estimates for Geron Co. Cut by Analyst (NASDAQ:GERN)
marketbeat.com - August 7 at 8:28 AM
finance.yahoo.com logoGeron Corporation (GERN) Stock Historical Prices & Data - Yahoo Finance
finance.yahoo.com - August 4 at 12:42 PM
markets.businessinsider.com logoGoldman Sachs Sticks to Their Hold Rating for Geron (GERN)
markets.businessinsider.com - August 4 at 12:42 PM
marketbeat.com logoGeron (NASDAQ:GERN) Earns Buy Rating from Needham & Company LLC
marketbeat.com - August 4 at 11:25 AM
finance.yahoo.com logoGeron (GERN) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 4 at 2:29 AM
washingtonpost.com logoGeron: Q2 Earnings Snapshot
washingtonpost.com - August 3 at 8:25 PM
markets.businessinsider.com logoGeron Corporation Q2 Loss increases, misses estimates
markets.businessinsider.com - August 3 at 8:25 PM
finance.yahoo.com logoGeron Corporation Reports Business Highlights and Second Quarter 2023 Financial Results
finance.yahoo.com - August 3 at 8:25 PM
Get Geron News Delivered to You Automatically

Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter.



GERN Media Mentions By Week

GERN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GERN
News Sentiment

0.94

0.82

Average
Medical
News Sentiment

GERN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GERN Articles
This Week

2

2

GERN Articles
Average Week

Get Geron News Delivered to You Automatically

Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:GERN) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -